SC
AZN icon

Savant Capital’s AstraZeneca AZN Stock Holding History

Savant Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.84M Buy
9,325
+393
+4% +$75.8K 0.01% 446
2025
Q4 		$1.64M Sell
8,932
-671
-7% -$118K 0.01% 443
2025
Q3 		$1.47M Sell
9,603
-233
-2% -$35.3K 0.01% 458
2025
Q2 		$1.37M Buy
9,836
+3,605
+58% +$505K 0.01% 437
2025
Q1 		$916K Sell
6,231
-16,682
-73% -$2.41M 0.01% 505
2024
Q4 		$3M Buy
22,913
+563
+3% +$78.8K 0.02% 328
2024
Q3 		$3.48M Buy
22,350
+2,063
+10% +$333K 0.03% 290
2024
Q2 		$3.16M Sell
20,287
-580
-3% -$87.3K 0.03% 273
2024
Q1 		$2.83M Sell
20,867
-158
-0.8% -$20.9K 0.03% 275
2023
Q4 		$2.83M Sell
21,025
-251
-1% -$32.6K 0.04% 230
2023
Q3 		$2.88M Sell
21,276
-254
-1% -$34.7K 0.04% 219
2023
Q2 		$3.08M Buy
21,530
+19,771
+1,124% +$2.91M 0.05% 213
2023
Q1 		$244K Buy
+1,759
New +$237K ﹤0.01% 643
2016
Q2 		– Sell
-3,907
Closed -$220K – 252
2016
Q1 		$220K Buy
+3,907
New +$235K 0.07% 206

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Savant Capital's AZN Position: Q1 2026 in Review

Savant Capital increased its AstraZeneca (AZN) stake by 4.4% in Q1 2026, buying an estimated $75.8K and bringing the position to 9,325 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #446.

Savant Capital first reported a position in AZN in Q1 2016 and has held it in 14 quarters since. The position peaked at $3.48M in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Savant Capital held 9,325 shares of AstraZeneca worth $1.84M as of Q1 2026.
  • Savant Capital bought 393 AstraZeneca shares in Q1 2026, an estimated $75.8K.
  • AstraZeneca made up 0.01% of Savant Capital's portfolio in Q1 2026, its #446 holding.
  • Savant Capital first reported a position in AstraZeneca in Q1 2016 and has held it in 14 quarters since.
  • Savant Capital's AstraZeneca position peaked at $3.48M in Q3 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.